Neurogenesis is defective in the AD model, which is characterized by decreased proliferation and differentiation, diminished neuronal maturity, and reduced survival, before processes that may secondarily affect neurogenesis, such as neuronal loss, amyloid deposition, and inflammation
Candidates are typically individuals who: Struggle with weight loss despite diet and exercise Want support with appetite control and cravings Are seeking a medically supervised approach to wellness Meet provider eligibility guidelines after consultation All patients must complete a medical intake and consultation with a licensed provider prior to treatment
Your clinician will help determine which Magnesium-containing IV therapy aligns with your goals
Airway-resident T cells from unexposed individuals cross-recognize SARS-CoV-2
You qualify under either pathway
Supports cellular detox and antioxidant defense